Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2013

Dec 6, 2013

30198_dirs_2013-12-06_3af9f7e7-a404-4cb1-85fe-b18ca33cf95f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2013-11-22

Reporting Person: KAHN BARBARA (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-22 Common Stock S 1500.0 $32.625 Disposed 49263 Direct

Footnotes

F1: Included in this number are 17,688 unvested restricted stock units, 11,130 of which were granted on May 31, 2013 and shall vest through May 31, 2014, and 6,558 of which were granted on May 26, 2011 and shall vest through May 26, 2014.